-
Mashup Score: 0
This year’s theme is perfectly timed for the current state of HIV care in the U.S., from the progress made to the need for collection action to address the challenges that remain.
Source: www.idsociety.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 21Long-acting injectable drug prevents HIV infections - 6 month(s) ago
New AIDS strategy acts like a vaccine and could avoid requiring people to take pills daily to prevent infections
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet-
It’s not an AIDS vaccine but it may be the closest thing to one so far. #WorldAIDSDay https://t.co/Ze17jD3hq7
-
-
Mashup Score: 1For People Living with HIV/AIDS, TB is… | American Thoracic Society - 6 month(s) ago
On World AIDS Day, the Forum of International Respiratory Societies highlights the need for a global response to the crisis.
Source: site.thoracic.orgCategories: General Medicine News, PulmonologyTweet-
This #WorldAidsDay, @FIRS_LungsFirst of which the ATS is a founding member, calls on governments, health advocates, and non-government organizations to strengthen their response to AIDS and TB. Full press release: https://t.co/Td4C765meg https://t.co/Bxh5WU0ww6
-
-
Mashup Score: 19Lenacapavir for Individuals Adherent to Daily Oral PrEP - 6 month(s) ago
This Viewpoint discusses the potential advantages of injectable preexposure prophylaxis (PrEP) drugs such as lenacapavir for persons unable to adhere to daily oral HIV PrEP and highlights ways in which lenacapavir and expanded PrEP options could offer tailored and effective ways to better meet the…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
Viewpoint: While long-acting injectable HIV PrEP options like lenacapavir show promise, equitable access, cost-effectiveness, and addressing adherence challenges with oral PrEP remain crucial for maximizing global HIV prevention efforts. #WorldAIDSDay https://t.co/mxK7noN3Tu https://t.co/Jxnqyt6vLG
-
-
Mashup Score: 8Overcoming Hepatitis B Vaccine Nonresponsiveness - 6 month(s) ago
Hepatitis B virus (HBV) infection continues to pose a significant global health challenge despite the availability of effective vaccines for more than 4 decades and antivirals for almost 3 decades. The World Health Organization estimates that more than 254 million people worldwide are living with…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
Editorial from @IvanHung2 and Anna Lok: New hepatitis B vaccine with a CpG adjuvant (HepB-CpG) shows promise for achieving higher and faster immune response in individuals with HIV who didn't respond to previous vaccination. #WorldAIDSDay https://t.co/XCXhYTJnJK https://t.co/0nOEn0SwNW
-
-
Mashup Score: 56
This randomized clinical trial compares the seroprotection response achieved with a 2-dose and a 3-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant vs a conventional 3-dose hepatitis B vaccine with an aluminum hydroxide adjuvant in people with HIV and prior nonresponse to hepatitis B…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
Both a 2-dose and a 3-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant showed a superior seroprotection response compared to 3 doses of the conventional HepB-alum vaccine. #WorldAIDSDay https://t.co/uWkQtdHT74 https://t.co/gvIvMdZ56w
-
-
Mashup Score: 8Advances in Treatment and Prevention of HIV - 6 month(s) ago
Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition and provides the tools that might lead to an end of the HIV pandemic. Despite these advances, in the United States there were approximately 30 000 new infections in 2022, less than 70% of people…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
@IAS_USA Editorial: 2024 @IAS_USA's recommendations highlight advancements in simplifying regimens, new options for PrEP, and importance of access to care. #WorldAIDSDay https://t.co/DEQ0iy811v https://t.co/Ua6J9AsgIV
-
-
Mashup Score: 15IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults - 6 month(s) ago
This Special Communication from the International Antiviral Society–USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
Special Communication from @IAS_USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention. https://t.co/SldKEb6wJG #WorldAIDSDay 🧵 https://t.co/oudaW24i2j
-
-
Mashup Score: 3HIV Information and Youth - 6 month(s) ago
Addressing HIV in youth requires young people have access to information and tools needed to reduce risk, make healthy decisions, and get treatment.
Source: www.cdc.govCategories: General Medicine News, PediatricsTweet-
1 in 5 new HIV diagnoses occurs in young people ages 13-24. This #WorldAIDSDay, learn more about why investing in health education and services for youth is critical to ending HIV. https://t.co/j7l0B0Cp5L https://t.co/SCa1YiCjad
-
-
Mashup Score: 4For People Living With HIV/AIDS, TB Is Still the Leading Cause of Death - American College of Chest Physicians - 6 month(s) ago
Together with the Forum of International Respiratory Societies, the American College of Chest Physicians is bringing attention to World AIDS Day.
Source: www.chestnet.orgCategories: General Medicine News, PulmonologyTweet-
Together with the Forum of International Respiratory Societies (@firs_lungsfirst), CHEST is calling on governments, health advocates, and nongovernment organizations to strengthen their response to AIDS and TB in support of #WorldAIDSDay. Read more: https://t.co/ZzpOpQFQai https://t.co/4CJanD9Tb9
-
On IDSA’s & @HIVMA’s Science Speaks blog: HIVMA Board member Joseph Cherabie, MD, MSc (@JncherabieMD) reflects on #WorldAIDSDay, from progress made in addressing HIV in the U.S. to the need for collection action to address the challenges that remain. https://t.co/9BOmo7KzBp